BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2901936)

  • 21. Aplastic anemia associated with initiation of nizatidine therapy in a hemodialysis patient.
    Nakano T; Kuroiwa T; Tsumita Y; Kaneko Y; Hiromura K; Ueki K; Nojima Y
    Clin Exp Nephrol; 2004 Jun; 8(2):160-2. PubMed ID: 15235935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs recently released in Belgium. Recombinant human erythropoietin--nizatidine.
    Harvengt C
    Acta Clin Belg; 1989; 44(6):419-22. PubMed ID: 2576492
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
    Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Today's treatment of chronic duodenal ulcer. H2 antagonists and the role of surgery.
    Clark CG
    Practitioner; 1983 Apr; 227(1378):543-6. PubMed ID: 6134276
    [No Abstract]   [Full Text] [Related]  

  • 25. Response to "H2-receptor antagonists and duodenal ulcer recurrence".
    Kurata JH; Nogawa AN; Koch GG
    Am J Gastroenterol; 1988 Dec; 83(12):1427-9. PubMed ID: 2904219
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nizatidine: a meta-analytical study].
    di Ciommo V; Ferrario F
    Clin Ter; 1993 Sep; 143(3):201-7. PubMed ID: 8222550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of gastrectomy in United States army hospitals worldwide from 1975 to 1985.
    Burkhalter E
    Am J Gastroenterol; 1988 Nov; 83(11):1231-4. PubMed ID: 2903660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Famotidine: an evolution in H2 antagonist therapy. Proceedings of a symposium. São Paulo, Brazil, September 7-12, 1986.
    J Clin Gastroenterol; 1987; 9 Suppl 2():1-27. PubMed ID: 2887612
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety of nizatidine in clinical trials conducted in the USA and Europe.
    Cloud ML
    Scand J Gastroenterol Suppl; 1987; 136():29-36. PubMed ID: 2892253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H2-receptor antagonist non-responders.
    Lancet; 1988 Jan; 1(8577):127-9. PubMed ID: 2891976
    [No Abstract]   [Full Text] [Related]  

  • 31. Duodenal ulcer: an update.
    Wormsley KG
    Mt Sinai J Med; 1981; 48(5):391-6. PubMed ID: 6117792
    [No Abstract]   [Full Text] [Related]  

  • 32. [Action of histamine H2 receptor blockaders on gastric motor function in duodenal peptic ulcer].
    Shcherbak VV; Glubochenko VG; Zaĭdman VE
    Klin Med (Mosk); 1984 Jun; 62(6):94-6. PubMed ID: 6147438
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pathogenesis, diagnosis and therapy of ulcer disease. Therapy. 4: Pharmacological basis and therapy with H2 antagonist].
    Med Welt; 1983 Dec; 34(49):20, 22. PubMed ID: 6140616
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
    Carella G
    Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 36. Can the H2 receptor antagonists change the natural history of duodenal ulcer disease?
    Bardhan KD
    Am J Gastroenterol; 1994 Jan; 89(1):3-6. PubMed ID: 7903845
    [No Abstract]   [Full Text] [Related]  

  • 37. New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
    Amarapurkar DN; Parikh SS; Desai HG
    J Assoc Physicians India; 1993 Aug; 41(8):496-7. PubMed ID: 7904993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
    Thomas JM; Misiewicz G
    Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
    [No Abstract]   [Full Text] [Related]  

  • 39. Famotidine: clinical applications of a new H2-receptor antagonist. Introduction.
    Texter EC
    Am J Med; 1986 Oct; 81(4B):1-2. PubMed ID: 2877567
    [No Abstract]   [Full Text] [Related]  

  • 40. Ranitidine and cimetidine for duodenal ulcer.
    Langman MJ; Henry DA; Ogilvie A
    Scand J Gastroenterol Suppl; 1981 Jun; 69():115-7. PubMed ID: 6119774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.